A Large-Scale Study Identifies a TgAb Interference Threshold for Thyroglobulin Immunoassays Using Segmented Regression and Bootstrap Validation
The Journal of Applied Laboratory Medicine · 2026
DOI: 10.1093/jalm/jfag072 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift The Journal of Applied Laboratory Medicine, 2026. Verfasst von Qianhui Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Thyroglobulin, Thyroid Neoplasms, Autoantibodies, Thyroid Cancer, Papillary. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Thyroglobulin (Tg) measurement is key for differentiated thyroid cancer (DTC) follow-up, but anti-Tg antibodies (TgAbs) can interfere with Tg immunoassays and bias Tg interpretation. Current TgAb cutoffs are heterogeneous, and an assay-specific interference threshold is needed.
Methods
We analyzed 85 949 euthyroid health-screening records (Roche e801 platform) using segmented linear regression and 1000 bootstrap resamples to estimate a TgAb interference threshold. For external validation, 125 TgAb-positive post-thyroidectomy papillary thyroid carcinoma (PTC) patients were included, and receiver operating characteristic (ROC) analyses were performed. Two ROC analyses were performed: (a) low-TgAb patients without structural recurrence (Group A) vs patients with structural recurrence (Group C), and (b) Groups A + B (no structural recurrence, including persistently elevated TgAb) vs Group C.
Results
The population-derived TgAb interference threshold was 48.1 U/mL (95% CI, 45.1–50.6). Above this level, Tg values shifted toward lower ranges with increased distributional asymmetry. In the PTC validation cohort, ROC-derived thresholds were 45.64 U/mL (A vs C) and 50.14 U/mL (A + B vs C), with areas under the curve (AUCs) of 1.00 and 0.8764, supporting internal stability and clinical concordance.
Conclusion
On the Roche cobas e801 platform, a TgAb level near 48 U/mL provides a pragmatic interference threshold for Tg immunoassay interpretation. This threshold stratifies Tg interpretability and is concordant with ROC-derived cutoffs from clinically defined comparisons in a TgAb-positive PTC cohort.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, China.
ORCID-Profile: Qianhui Liu
Zitieren
APA
Liu, Q., You, L., Lv, H., Zhang, C., & Li, G. (2026). A Large-Scale Study Identifies a TgAb Interference Threshold for Thyroglobulin Immunoassays Using Segmented Regression and Bootstrap Validation. The Journal of Applied Laboratory Medicine. https://doi.org/10.1093/jalm/jfag072
Vancouver
Liu Q, You L, Lv H, Zhang C, Li G. A Large-Scale Study Identifies a TgAb Interference Threshold for Thyroglobulin Immunoassays Using Segmented Regression and Bootstrap Validation. The Journal of Applied Laboratory Medicine. 2026. doi:10.1093/jalm/jfag072
BibTeX
@article{Liu2026,
author = {Liu, Qianhui and You, Lan and Lv, Heye and Zhang, Chunying and Li, Guixing},
title = {A Large-Scale Study Identifies a TgAb Interference Threshold for Thyroglobulin Immunoassays Using Segmented Regression and Bootstrap Validation},
journal = {The Journal of Applied Laboratory Medicine},
year = {2026},
doi = {10.1093/jalm/jfag072}
}
EUVIMED